How big is the Global Biosimilars Market?

The Global Biosimilars Market size is expected to reach USD 35.47 billion in 2024 and grow at a CAGR of 18.32% to reach USD 82.27 billion by 2029. Read More

What is the current Global Biosimilars Market size?

In 2024, the Global Biosimilars Market size is expected to reach USD 35.47 billion. Read More

Who are the key players in Global Biosimilars Market?

Pfizer Inc, Novartis AG, Samsung Bioepies Co., Ltd, Coherus Biosciences, Inc. and Amgen Inc are the major companies operating in the Global Biosimilars Market. Read More

Which is the fastest growing region in Global Biosimilars Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Biosimilars Market?

In 2024, the North America accounts for the largest market share in Global Biosimilars Market. Read More

What years does this Global Biosimilars Market cover, and what was the market size in 2023?

In 2023, the Global Biosimilars Market size was estimated at USD 28.97 billion. The report covers the Global Biosimilars Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Biosimilars Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the growth drivers of the Biosimilar Market?

The growth drivers of the Biosimilar Market are a) Several blockbuster biopharmaceuticals going off-patent over the next five to ten years b) The increasing demand for biosimilar drugs due to their cost effectiveness Read More

What are the major restraints in the Biosimilars Market?

The major restraints in the Biosimilars Market are a) High-cost involvement and complexities in manufacturing b) Concerns regarding substitutability and interchangeability Read More

Biosimilars Market Size | Industry Growth & Forecast Report

Biosimilars Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)

The Global Biosimilars Market is Segmented by Product Class (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Other Product Classes), Applications (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Biosimilars Industry Overview

The market is highly competitive, with many of the largest biosimilar companies dominating the market. The major players in the studied market comprise Novartis AG, Pfizer Inc., Amgen Inc., Coherus Biosciences Inc., Mylan NV (Viatris Inc.), and Samsung Bioepis Co., Ltd., among others. Most top biosimilar companies are adopting various growth strategies, such as acquisitions, partnerships, and new product launches, to secure their position in the global market.